Form 4: CoreWeave CDO Sells 131,330 Shares via 10b5-1 Plan

CoreWeave's Chief Development Officer, Brannin McBee, executed sales of Class A Common Stock totaling 131,330 shares through a pre-arranged 10b5-1 trading plan.

Summary

• Brannin McBee, Chief Development Officer of CoreWeave, Inc. (CRWV), reported transactions on February 2, 2026, which included conversions of Class B Common Stock to Class A Common Stock and subsequent sales of Class A Common Stock.
• All reported sales were executed pursuant to a Rule 10b5-1 trading plan adopted on November 17, 2025.
• A total of 131,330 Class A Common Stock shares were sold across direct and indirect holdings.
• Direct sales by Mr. McBee totaled 102,830 Class A Common Stock shares at weighted average prices ranging from $89.0342 to $94.3646.
• Sales from the Brannin J McBee 2022 Irrevocable Trust totaled 25,000 Class A Common Stock shares at weighted average prices ranging from $89.0342 to $94.3652.
• Sales from the Canis Major 2024 Irrevocable Trust LLC totaled 3,000 Class A Common Stock shares at weighted average prices ranging from $89.0978 to $94.65.
• Sales from the Canis Major SM Trust totaled 500 Class A Common Stock shares at weighted average prices ranging from $89.0957 to $94.65.
• Following these transactions, Mr. McBee directly beneficially owns 248,664 Class A Common Stock and 8,397,320 Class B Common Stock.
• Indirect beneficial ownership includes 4,016,020 Class B Common Stock via the Brannin J. McBee 2022 Irrevocable Trust, 330,000 Class B Common Stock via the Canis Major 2024 Irrevocable Trust LLC, 55,000 Class A Common Stock via the Canis Major SM Trust, 1,800 Class A Common Stock via his child, and 2,280,300 Class B Common Stock via his spouse.
• This Form 4 is Part 1 of 2 for this reporting person.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a moderately negative signal due to significant insider selling, although the pre-arranged 10b5-1 plan suggests the transactions are not based on new, non-public information.

Negatives

• Significant insider selling of 131,330 Class A Common Stock shares by the Chief Development Officer and related trusts.
• While executed under a 10b5-1 plan, such sales can sometimes be perceived by the market as a signal of reduced confidence, even if not based on new material non-public information.

Future Outlook

NA

Industry Context

StockSavvy.ai notes that insider selling, even under a 10b5-1 plan, is a common occurrence but can sometimes be interpreted by the market as a signal, though these plans are designed to mitigate such interpretations by pre-scheduling trades. The volume of shares sold by a Chief Development Officer could draw attention.

Related Party Transactions

• Sales of Class A Common Stock from the Brannin J McBee 2022 Irrevocable Trust, where the reporting person's spouse and minor child are beneficiaries and the spouse serves as trustee.
• Sales of Class A Common Stock from the Canis Major 2024 Irrevocable Trust LLC, where the reporting person serves as manager.
• Sales of Class A Common Stock from the Canis Major SM Trust, an irrevocable trust with a third-party trustee, where the reporting person's minor child is beneficiary and the reporting person has the power to remove and replace the trustee.
• Beneficial ownership of 1,800 Class A Common Stock by the reporting person's child.
• Beneficial ownership of 2,280,300 Class B Common Stock by the reporting person's spouse.

Stakeholder Impact

• Shareholders might interpret the insider selling as a lack of confidence, potentially leading to downward pressure on the stock price.

Key Dates

Recommendation

The Chief Development Officer's sale of a substantial number of shares, while executed under a pre-arranged 10b5-1 plan, represents a reduction in insider ownership. This could be perceived negatively by the market, but the planned nature of the sale suggests it's not based on new adverse information. Investors should monitor future filings and company performance, maintaining a 'hold' position in the interim.

Keywords

CoreWeave, CRWV, Form 4, insider trading, stock sale, 10b5-1 plan, Brannin McBee, Chief Development Officer, equity